Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NxStage's home haemodialysis system:

This article was originally published in Clinica

Executive Summary

Making its portable haemodialysis system available beyond hospital and clinic settings, NxStage Medical has gained US FDA 510(k) clearance to market its System One device for daily home use. Claimed by the Lawrence, Massachusetts firm to be the smallest commercially available haemodialysis device, System One plugs into standard electrical outlets and requires no special infrastructure to operate, allowing its use also by patients who want to travel. There is a growing body of literature supporting the clinical benefits of more frequent dialysis, often administered in the home, the company noted.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT055668

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel